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pAortic Event Rate in the Marfan Population: A Cohort Study
Jondeau G, Detaint D, Tubach F, et al. Circulation 2012;125:226-32.
Conclusion: Patients withMarfan syndrome who have ascending aorta
diameters of 50 mm have a low risk of sudden death or aortic dissection.
Fifty millimeters is a reasonable threshold for prophylactic aortic surgery in
patients with Marfan syndrome.
Summary: During the last 30 years, the life expectancy for patients
with Marfan syndrome has increased by 30 years (Pyeritz RE, et al, Heart
2009;95:173-5). Improvement of survival in patients withMarfan syndrome
is likely multifactorial but includes more widespread practice of routine
imaging and timed prophylactic aortic surgery. Two recent task forces have
proposed a 50-mm aortic diameter at the level of the sinus of Valsalva as
the cutoff value for performing ascending aortic surgery; however, no value
has been specifically proposed for patients with Marfan syndrome. All
patients in this study fulfilled international criteria for Marfan syndrome and
had not had previous aortic surgery or dissection. Patients must have come
to the authors’ center at least two times to be included in this study.
Echocardiography was used to make aortic measurements every 2 years, and
patients were given systemic  blockade and advised to avoid intense sports
activity. When the aortic root maximum diameter reached 50 mm, prophy-
lactic surgery was proposed. There were 732 patients withMarfan syndrome
followed up for a mean of 6.6 years. During follow-up, two dissections and
five deaths occurred. Event rate (death/aortic dissection) was 0.17% per
year. Risk increased if the aortic diameter increased within 2 years of the
event, from 0.09% per year (95% confidence interval [CI], 0.00%-0.20%)
when the aortic diameter was40mm to 0.3% (95% CI, 0.00%-0.71%) with
aortic diameters of 45 to 49 mm and to 1.3% (95% CI, 0.00%-3.93%) with
aortic diameters of 50 to 54 mm. Aortic diameters 50 mm increased the
risk four times. The annual risk was 0.05% when the aortic diameter was
50 mm after the authors excluded a neonatal patient, a woman who
became pregnant, and a 72-year-old woman with previous myocardial
infarction.
Comment: The results suggest that aortic dissection in patients with
Marfan syndrome can be almost entirely prevented with the use of systemic
-blockers, avoidance of intense sporting activities, and scheduled surgery
when the aortic root reaches 5 cm in diameter. Patients with Marfan
syndrome can do very well with strict compliance with medical advice and
timed prophylactic surgery.
Atherosclerosis Screening by Noninvasive Imaging for Cardiovascular
Prevention: A Systematic Review
Rodondi N, Auer R, de Bosset Sulzer V, et al. J Gen Intern Med 2011;27:
220-31.
Conclusions: There is limited evidence concerning atherosclerosis
screening, with mixed results on whether screening improves cardiovascular
risk factors, no data on cardiovascular events, and only one study suggesting
smoking cessation increased after identification of atherosclerosis deter-
mined through screening. Screening for atherosclerosis should be validated
through clinical trials before widespread use is advocated.
Summary: Possible noninvasive methods for screening for atheroscle-
rosis include measurement of ultrasound-determined carotid intima-media
thickness or carotid plaques, computed tomography imaging to assess for
aortic calcification, ankle-brachial index, and flow-mediated brachial artery
endothelial vasodilation. Indeed, there are measures of atherosclerosis that
appear to improve the prediction of coronary heart disease events (O’Leary
DH et al, N Engl J Med 1999;340:14-22; Fowkes FG et al, JAMA
2008;300:197-208). However, prediction of events does not necessarily
lead to effective prevention of events (Lauer MS et al, N Engl J Med
2009;361:841-3; Young LH et al, JAMA 2009;301:1547-55). There is
therefore significant controversy about the role of atherosclerosis screening
in the routine clinical care of patients. The authors performed a systematic
review to assess whether screening for atherosclerosis results in improvement
in cardiovascular risk factors and in clinical outcomes. The authors searched
MEDLINE and the Cochrane Clinical Trial Registry, without language
restrictions, to identify studies to include in the review. Included studies
were those assessing the impact of atherosclerosis screening with noninvasive
imaging on cardiovascular risk factors, cardiovascular events, or mortality in
adults without known cardiovascular disease. The authors identified four
randomized control trials (RCT, n 709) and eight nonrandomized studies
comparing participants with evidence of atherosclerosis on screening with
those without evidence of atherosclerosis (n 2994). In the RCTs, screen-
ing for atherosclerosis did not improve cardiovascular risk factors but did
seem to result in an increase in stop-smoking rates (18% vs 6%, P  .03).
Nonrandomized studies found improvements in some intermediate out-
t
iomes such as an increased motivation to change lifestyle and increased
erception of cardiovascular risk. Data, however, were conflicting and
imited by lack of a randomized control group. No studies examined the
mpact of screening on cardiovascular events or death. Pooling of results was
ot possible because of extensive heterogeneity in screening methods and
tudied outcomes.
Comment: Screening for atherosclerosis seems like a good idea. The
nfortunate reality, however, is that there are no data to justify the expense
nd effort of noninvasive testing to screen for atherosclerosis. There are, in
act, no studies examining the impact of screening on cardiovascular events
r death. It will be difficult to ever perform such a trial. A National Heart,
ung, and Blood Institute working group estimated that a trial on the
mpact of screening for atherosclerosis on clinical cardiovascular events
ould require 10,000 participants (http://www.nhlbi.nih.gov/meet-
ngs-
orkshops). Trials addressing the impact of noninvasive diagnostic tech-
iques for screening for atherosclerosis are therefore not likely to be con-
ucted anytime soon. Screening for atherosclerosis remains an expensive,
ikely low yield, and unproven concept.
ower-Extremity Endovascular Interventions for Medicare Beneficia-
ies: Comparative Effectiveness as a Function of Provider Specialty
afar AM, Dhangana R, Murphy TP, et al. J Vasc Interv Radiol 2012;23:
-9.
Conclusion: The authors conclude that Medicare data demonstrate
ndovascular lower extremity revascularizations “by vascular surgeons result
n more transfusions and ICU use, longer hospital stays, more repeat
evascularization procedures or amputations, and higher costs compared
ith procedures performed by interventional radiologists.”
Summary: This report was written on a background of increasing
arginalization of interventional radiologists in the performance of lower
xtremity endovascular interventions. The authors’ data indicate that inter-
entional radiologists between 2005 and 2007 performed only 25% of
ower extremity endovascular interventions. Given the ever-increasing in-
olvement of vascular surgeons and interventional cardiologists in the per-
ormance of lower extremity interventions, that percentage may be even less
n 2012. It is on this background that the authors, who are primarily
adiologists, reported to perform an unbiased examination of specialty-
pecific trends and outcomes of lower extremity revascularization in Medi-
are beneficiaries. They used Medicare Standard Analytical Files containing
ongitudinal data of all services (physician, inpatient, outpatient) provided to
5% sample of Medicare beneficiaries. They extracted claims for percutane-
us angioplasty, atherectomy, and stent implantation of lower extremity
rteries during the years 2005 to 2007. Outcomes assessed included mor-
ality, transfusion, intensive care unit use, length of stay, and subsequent
evascularization or amputation. Outcomes were then compared using
egression models adjusted for age, sex, race, emergencies, department
dmission, and comorbid conditions. It does not appear adjustments were
ade for length of lesion treated, stenosis vs occlusion, or whether endo-
ascular procedures were performed as planned adjuncts to an open proce-
ure or a planned amputation. There also do not appear to be adjustments
or indication of procedure, size or location of pedal wounds, or referral
ource. Using the analysis performed and with all the limitations noted
bove, adjusted 1-year procedure costs were lower for interventional radiol-
gists ($17,640) than for vascular surgeons ($19,012) or interventional
ardiologists ($19,096).
Comment: The basic problem here, in addition to what can as best be
escribed as a self-serving analysis, is that the database used and the data used
o perform the analysis in this report are insufficient to draw any reasonable
onclusions. Many of the important variables determining the technical
utcomes of endovascular interventions cannot be properly adjusted for
sing the database used in this article. Given the obvious limitations of the
atabase, it is amazing the manuscript was published without a more
horough discussion of its limitations. My personal experience with inter-
entional radiologists at our institution is that they are keenly cognizant of
he limitations of endovascular intervention. One would hope the authors of
his report, and the editors and reviewers for the Journal of Vascular and
nterventional Radiology, would have demonstrated a similar understanding
f these limitations. If the apparent lack of insight reflected in this article
eflects that of most radiologists, then perhaps it is a good thing they are
erforming proportionally fewer lower extremity endovascular interven-
ions. Please see also the commentary by Dr Richard Cambria also appearing
n this issue of the Journal.
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